Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1158707

Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting

Omrčen Tomislav, Eterović Davor, Vrdoljak Eduard
Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting // 11th European Multidisciplinary Congress on Urological Cancers: Implementing multidisciplinary strategies in genito-urinary cancers. European Urology Supplements. 2019 ; 18(11)
Beč, Austrija: Elsevier, 2019. str. 3491-3492 doi:10.1016/ S1569-9056(19)34647-0 (poster, međunarodna recenzija, prošireni sažetak, stručni)

CROSBI ID: 1158707 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting

Autori
Omrčen Tomislav, Eterović Davor, Vrdoljak Eduard

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, prošireni sažetak, stručni

Izvornik
11th European Multidisciplinary Congress on Urological Cancers: Implementing multidisciplinary strategies in genito-urinary cancers. European Urology Supplements. 2019 ; 18(11) / - : Elsevier, 2019, 3491-3492

Skup
11. European Multidisciplinary Congress on Urological Cancers

Mjesto i datum
Beč, Austrija, 14.11.2019. - 17.11.2019

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
abiraterone, enzalutamide, prostate cancer, resistance

Sažetak
Predictors of resistance of abiraterone and enzalutamide in metastatic castration resistant prostate cancer.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
KBC Split,
Medicinski fakultet, Split

Profili:

Avatar Url Eduard Vrdoljak (autor)

Avatar Url Davor Eterović (autor)

Avatar Url Tomislav Omrčen (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Omrčen Tomislav, Eterović Davor, Vrdoljak Eduard
Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting // 11th European Multidisciplinary Congress on Urological Cancers: Implementing multidisciplinary strategies in genito-urinary cancers. European Urology Supplements. 2019 ; 18(11)
Beč, Austrija: Elsevier, 2019. str. 3491-3492 doi:10.1016/ S1569-9056(19)34647-0 (poster, međunarodna recenzija, prošireni sažetak, stručni)
Omrčen Tomislav, Eterović Davor, Vrdoljak Eduard (2019) Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting. U: 11th European Multidisciplinary Congress on Urological Cancers: Implementing multidisciplinary strategies in genito-urinary cancers. European Urology Supplements. 2019 ; 18(11) doi:10.1016/ S1569-9056(19)34647-0.
@article{article, year = {2019}, pages = {3491-3492}, DOI = {10.1016/ S1569-9056(19)34647-0}, keywords = {abiraterone, enzalutamide, prostate cancer, resistance}, doi = {10.1016/ S1569-9056(19)34647-0}, title = {Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting}, keyword = {abiraterone, enzalutamide, prostate cancer, resistance}, publisher = {Elsevier}, publisherplace = {Be\v{c}, Austrija} }
@article{article, year = {2019}, pages = {3491-3492}, DOI = {10.1016/ S1569-9056(19)34647-0}, keywords = {abiraterone, enzalutamide, prostate cancer, resistance}, doi = {10.1016/ S1569-9056(19)34647-0}, title = {Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting}, keyword = {abiraterone, enzalutamide, prostate cancer, resistance}, publisher = {Elsevier}, publisherplace = {Be\v{c}, Austrija} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.